CLOSTRIDIUM DIFFICILE COLITIS: THE ROLE OF SURGERY AND FECAL MICROBIOTA TRANSPLANT
Аннотация
Об авторах
Ladislav Mitáš
Masaryk University Brno
Россия
Россия
T. Skřička
Masaryk University Brno
Россия
Россия
L. Kunovský
Masaryk University Brno
Россия
Россия
P. Polák
Masaryk University Brno
Россия
Россия
Z. Kala
Masaryk University Brno
Россия
Россия
V. Čan
Masaryk University Brno
Россия
Россия
T. Dufková
Masaryk University Brno
Россия
Россия
E. Janoušová
Masaryk University Brno
Россия
Россия
M. Hansliánová
Masaryk University Brno
Россия
Россия
I. Penka
Masaryk University Brno
Россия
Россия
А. И. Москалев
Россия
Е. А. Ким
Россия
Список литературы
1. Ananthakrishnan, A.N. Clostridium difficile infection: epidemiology, risk factors and management. / A.N.Ananthakrishnan // Nat. Rev. Gastroenterol. Hepatol. - 2011. - № 8. - р. 17-26.
2. To, K.B. Clostridium difficile infection: update on diagnosis, epidemiology, and treatment strategies. / K.B.To, L.M.Napolitano // Surg. Infect. - 2014. -№ 15. - р. 490-502.
3. Hall, J.F. Outcome of colectomy for C.difficile colitis: a plea for early surgical management / J.F.Hall, D.Berger // Am. J. Surg. - 2008. - № 196. - р. 384-388.
4. Paredes-Sabja, D. Clostridium difficile spore biology: sporulation, germination, and spore structural proteins. / D.Paredes-Sabja, A.Shen, J.A.Sorg // Trends Microbiol. - 2014. - № 22. - р. 406-16.
5. Kuehne, S.A. Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain. / S.A.Kuehne, M.M.Collery, M.L.Kelly et al. // J. Infect. Dis. - 2014. - № 209 (1). - р. 83-6.
6. Bacci, S. Binary toxin and death after clostridium difficile infection. / S.Bacci, K.M0lbak, M.K.Kjeldsen et al. // Emerg. Infect. Dis. - 2011. - № 17. - р. 976-82.
7. Cohen, S.H. Clinical practice guidelines for Clostridium difficile infection in adults. / S.H.Cohen, D.N.Gerding, S.Johnson et al. // Infect. Control Hosp. Epidemiol. - 2010. - № 31 (5). - р. 431-455.
8. Freeman, J. The changing epidemiology of Clostridium difficile infections. / J.Freeman, M.P.Bauer, S.D.Baines et al. // Clin. Microbiol. Rev. -2010. - № 23. - р. 529-49.
9. Nitzan, O. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment. / O.Nitzan, M.Elias, B.Chazan et al. // World J. Gastroenterol. Т - 2013. - № 19. - р. 7577-85.
10. Surawicz, C.M. Treatment ofrecurrent Clostridium difficile-associated disease. / C.M.Surawicz // Nat. Clin. Pract. Gastroenterol. Hepatol. - 2004. - № 1. -р. 32-8.
11. Huebner, E.S. Treatment of recurrent Clostridium difficile diarrhea. / E.S.Huebner, C.M.Surawicz // Gastroenterol. Hepatol. - 2006. - № 2. - р. 203-8.
12. Brandt, L.J. Long-term follow-up of colonoscopic fecal microbiotia transplant for recurrent Clostridium difficile infection. / L.J.Brandt, O.C.Aroniadis, M.Mellow et al. // Am. J. Gastroenterol. - 2012. -№ 107. - р. 1079-1087.
13. Bauer, M. ECDIS Study Group. Clostridium difficile infection in Europe: a hospital-based survey. / M.Bauer, D.Notermans, B.van Benthem et al. // Lancet. - 2011. - № 377. - р. 63-73.
14. Debast, S.B. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. / S.B.Debast, M.P.Bauer, E.J.Kuijper // Clin. Microbiol. Infect. - 2014. - № 20 (suppl 2). p. 1-26.
15. Garey, K.W. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. / K.W.Garey, S.Sethi, Y.Yadav et al. // J. Hosp. Infect. - 2008. -№ 70 (4). - p. 298-304.
16. Leav, B.A. Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI). / B.A.Leav, B.Blair, M.Leney et al. // Vaccine. - 2010. - № 28 (4). - p. 965-969.
17. Surawicz, C.M. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. / C.M.Surawicz, L.J.Brandt, D.G.Binion et al. // Am. J. Gastroenterol. - 2013. - № 108. -р. 478-98.
18. O’Horo, J.C. Treatment of recurrent Clostridium difficile infection. / J.C.O’Horo, K.Jindai, B.Kunzer et al. // Infection. - 2014. - № 42 (1). - p. 43-59.
19. Sartelli, M. WSES guidelines for management of Clostridium difficile infection in surgical patients. / M.Sartelli, M.A.Malangoni, F.M.Abu-Zidan et al. // World. J. Emerg. Surg. - 2015 Aug. - № 20. - p. 10:38.
20. Gough, E. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. / E.Gough, H.Shaikh, A.R.Manges // Clin. Infect. Dis. - 2011 Nov. - № 53 (10). - p. 994-1002.
21. Cammarota, G. Fecalmicrobiota transplantation for the treatment of Clostridium difficile infection. / G.Cammarota, G.Ianiro, A.Gasbarrini // J. Clin. Gastroenterol. - 2014. - № 48 (8). - p. 693-702.
22. Bakken, J.S. Treating Clostridium difficile infection with fecal microbiota transplantation. / J.S.Bakken, T.Borody, L.J.Brandt et al. //Clin. Gastroenterol. Hepatol. - 2011. - № 9. - p. 1044-9.
23. Eiseman, B. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. / B.Eiseman, W.Silen, G.S.Bascom et al. // Surgery. -1958. - № 44. - p. 854-9.
24. Zhang, F. Should we standardize the 1,700-year old fecal microbiota transplantation? / F.Zhang, W.Luo, Y.Shi et al. // Am. J. Gastroenterol. - 2012. -№ 107. - p. 1755.
25. Polak, P. First experiences with faecal bacteriotherapy in the treatment of relapsing pseudomembranous colitis due to Clostridium difficile. / P.Polak, M.Freibergerova, J.Juranková et al. // Klin. Mikrobiol. Inf. Lek. - 2011. - № 17 (6). -p. 214-7.
26. Neal, M.D. Diverting loop ileostomy and colonic lavage. An alternative to total abdominal colectomy for treatment of severe complicated Clostridium difficile associated disease. / M.D.Neal, J.C.Alverdy, D.E.Hall et al. // Ann. Surg. - 2011. - № 254. - p. 423-429.
27. Girotra, M. Clinical predictors of fulminant colitis in patients with Clostridium difficile infection. / M.Girotra, V.Kumar, J.M.Khan et al. // Saudi J. Gastroenterol. - 2012. - № 18. - p. 133-9.
28. Kaiser, A.M. CME Committee of the SSAT. Clostridium Difficile Infection from a Surgical Perspective. / A.M.Kaiser, R.Hogen, L.Bordeianou et al. // J. Gastrointest. Surg. - 2015 Jul. - № 19 (7). -p. 1363-77.
29. Lamontagne, F. Impact of emergency colectomy on survival of patients with fulminant C.Difficile colitis during an epidemic caused by a hyper virulent strain. / F.Lamontagne, A.C.Labbé, O.Haeck et al. // Ann. Surg. - 2007. - № 245. - p. 267-272.
30. Dudukgian, H. C.difficile colitis-predictors of fatal outcome. / H.Dudukgian, E.Sie, C.Gonzalez-Ruiz et al. // J. Gastrointest. Surg. - 2010. - № 14. - p. 315-22.
31. Butala, P. Surgical aspects of fulminant Clostridium difficile colitis. / P.Butala, C.M.Divino // Am. J. Surg. - 2010. - № 200. - p. 131-5.
32. Seltman, A.K. Surgical Management of Clostridium difficile Colitis. / A.K.Seltman // Clin Colon Rectal Surg. - 2012. - № 25. - p. 204-209.
33. Dindo, D. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. / D.Dindo, N.Demartines, P.A.Clavien // Ann. Surg. - 2004. -№ 240. - p. 205-213.
34. Borody, T.J. Fecal microbiota transplantation: indications, methods, evidence, and future directions. / T.J.Borody, S.Paramsothy, G.Agrawal // Curr. Gastroenterol. Rep. - 2013 Aug. - № 15 (8) -p. 337.
35. van Nood, E. Duodenal infusion of donor feces for recurrent Clostridium difficile. / E.van Nood, A.Vrieze, M.Nieuwdorp et al. // N. Engl. J. Med. - 2013. -№ 368 (5). - p. 407-415.
36. Youngster, I. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. / I.Youngster, G.H.Russell, C.Pindar et al. // JAMA. - 2014. - № 312 (17). - p. 1772-8.
37. Benes, J. Diagnosis and therapy of Clostridium difficile infection: Czech national guidelines. / J.Benes, P.Husa, O.Nyc et al. // Klin. Mikrobiol. Inf. Lek. - 2014. - № 20 (2). - p. 56-66.
38. Wang, M.F. Current role of surgery for the treatment of fulminant Clostridium difficile colitis. / M.F.Wang, Z.Ding, J.Zhao et al. // Chin. Med. J. -2013. - № 126. - p. 949-56.
39. Bhangu, A. West Midlands Research Collaborative. Systematic review and meta-analysis of outcomes following emergency surgery for Clostridium difficile colitis. / A.Bhangu, D.Nepogodiev, A.Gupta et al. // Br. J. Surg. - 2012. - № 99. - p. 1501-13.
40. Sailhamer, E.A. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. / E.A.Sailhamer, K.Carson, Y.Chang et al. // Arch Surg. - 2009. - № 144. - p. 433-9.
41. Chan, S. Outcomes following colectomy for Clostridium difficile colitis. / S.Chan, M.Kelly, S.Helme et al. // International Journal of Surgery. -2009. - № 7. - p. 78-81.
42. Mitáš, L. Surgical treatment of Clostridium colitides. / L.Mitáš, R.Svatoň, T.Skřička et al. // Acta ChirIugosl. - 2012. - № 59 (2). - p. 63-9.
43. Skřička, T. Klostridial'nyjkolit - važnajaproblema v chirurgii. / T.Skricka, B.Hemmelova, L.Mitas et al. // Koloproktologija. - 2014. - № 50 (4). - p. 17-23.
44. Halabi, W.J. Clostridium difficile colitis in the United States: a decadeof trends, outcomes, risk factors for colectomy, and mortality after colectomy. / W.J.Halabi, V.Q.Nguyen, J.C.Carmichael et al. // J. Am. Coll. Surg. - 2013. - № 217. - p. 802-12.
45. Ferrada, P. Timing and type of surgical treatment of Clostridium difficile-associated disease: a practice management guideline from the Eastern Association for the Surgery of Trauma. / P.Ferrada, C.G.Velopulos, S.Sultan et al. // J. Trauma Acute Care Surg. - 2014. -№ 76. - p. 1484-93.
46. Koss, K. The outcome of surgery in fulminant Clostridium difficile colitis. / K.Koss, M.A.Clark, D.S.A.Sanders et al. // Colorectal Dis. - 2006. - № 8. -p. 149-54.
47. Ali, S.O. Early surgical intervention for fulminant pseudomebranous colitis. / Ali S.O., Welch J.P., Dring R.J. // Am. Surg. - 2008. - № 74. - p. 20-6.
48. Steele, S.R. Practice parameters for the management of Clostridium difficile infection. / S.R.Steele, J.McCormick, G.B.Melton et al. // Dis. Colon Rectum. - 2015. - № 58. - p. 10-24.
Рецензия
Для цитирования:
., ., ., ., ., ., ., ., ., ., Москалев А.И., Ким Е.А. . Колопроктология. 2018;(3):24-43.
For citation:
Mitáš L., Skřička T..., Kunovský L..., Polák P..., Kala Z..., Čan V..., Dufková T..., Janoušová E..., Hansliánová M..., Penka I..., ., . CLOSTRIDIUM DIFFICILE COLITIS: THE ROLE OF SURGERY AND FECAL MICROBIOTA TRANSPLANT. Koloproktologia. 2018;(3):24-43.
Просмотров: 202
Послать статью по эл. почте 
